Literature DB >> 20835702

Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?

P Ramakant1, A K Verma, R Misra, K N Prasad, G Chand, A Mishra, G Agarwal, A Agarwal, S K Mishra.   

Abstract

AIMS/HYPOTHESIS: We studied the bacterial aetiology and antibiotic sensitivity pattern of diabetic foot ulcers in India.
METHODS: Records of 447 hospitalised patients between 1991 and 2008 were retrospectively analysed between two time periods (before and after 1999) to compare bacterial aetiology and antimicrobial sensitivity patterns. The first three consecutive cultures from the same wound during treatment were evaluated.
RESULTS: Of 1,632 cultures, 66% were polymicrobial, 23% monomicrobial and 11% sterile. In the monomicrobial group, 14% (n = 228) of cultures were Gram-negative, whereas 9% (n = 147) were Gram-positive. The most common pathogens in the first culture were Pseudomonas aeruginosa (20.1%), Staphylococcus aureus (17.2%) and Escherichia coli (16.3%). Results for the third cultures showed persistence of P. aeruginosa (15.3%) and E. coli (14.2%). Gram-negative isolates dominated over Gram-positive ones (25.3% vs 15.1%, p < 0.05). Antibiotic sensitivity patterns before and after 1999 were: piperacillin-tazobactam 74% vs 66% (p < 0.005), imipenem 77% vs 85% (NS), cefoperazone-sulbactam 47% vs 44% (p < 0.005), amikacin 62% vs 78% (NS), ceftriaxone 41% vs 36% (p < 0.005), amoxicillin-clavulanate 51% vs 43% (p < 0.05) and clindamycin 43% vs 36% (p < 0.005), respectively. CONCLUSIONS/
INTERPRETATION: Unlike in the West, in India Gram-negative bacteria were found to have always been dominant in the wounds of patients with diabetic foot infections. Infection with polymicrobial multidrug-resistant Gram-negative bacilli is common. The policy of empirical antimicrobial therapy at tertiary care needs to be changed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835702     DOI: 10.1007/s00125-010-1893-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute.

Authors:  M S Kumar; V Lakshmi; R Rajagopalan
Journal:  Indian J Med Microbiol       Date:  2006-07       Impact factor: 0.985

2.  A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital.

Authors:  Ravisekhar Gadepalli; Benu Dhawan; Vishnubhatla Sreenivas; Arti Kapil; A C Ammini; Rama Chaudhry
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  A microbiological study of diabetic foot lesions.

Authors:  E W Jones; R Edwards; R Finch; W J Jeffcoate
Journal:  Diabet Med       Date:  1985-05       Impact factor: 4.359

4.  Irrational drug use in India: a prescription survey from Goa.

Authors:  V Patel; R Vaidya; D Naik; P Borker
Journal:  J Postgrad Med       Date:  2005 Jan-Mar       Impact factor: 1.476

5.  Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem.

Authors:  C N Dang; Y D M Prasad; A J M Boulton; E B Jude
Journal:  Diabet Med       Date:  2003-02       Impact factor: 4.359

6.  Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.

Authors:  G Pellizzer; M Strazzabosco; S Presi; F Furlan; L Lora; P Benedetti; M Bonato; G Erle; F de Lalla
Journal:  Diabet Med       Date:  2001-10       Impact factor: 4.359

Review 7.  Validation of Wagner's classification: a literature review.

Authors:  Robert G Smith
Journal:  Ostomy Wound Manage       Date:  2003-01       Impact factor: 2.629

8.  Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience.

Authors:  K N Prasad; N Prasad; A Gupta; R K Sharma; A K Verma; A Ayyagari
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

9.  Management of diabetic foot infections in an era of increasing microbial resistance.

Authors:  Sandra Bliss Nelson
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

Review 10.  Antibacterial resistance: current problems and possible solutions.

Authors:  Rashmi Sharma; Chaman Lal Sharma; Bhuvneshwar Kapoor
Journal:  Indian J Med Sci       Date:  2005-03
View more
  34 in total

1.  Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model.

Authors:  Stephanie DeLeon; Allie Clinton; Haley Fowler; Jake Everett; Alexander R Horswill; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.

Authors:  Andreas Ambrosch; Simone Haefner; Edward Jude; Ralf Lobmann
Journal:  Int Wound J       Date:  2011-08-23       Impact factor: 3.315

Review 3.  The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey.

Authors:  M Hatipoglu; M Mutluoglu; G Uzun; E Karabacak; V Turhan; B A Lipsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

4.  Antibacterial activities of selected medicinal plants in traditional treatment of human wounds in Ethiopia.

Authors:  Biruhalem Taye; Mirutse Giday; Abebe Animut; Jemal Seid
Journal:  Asian Pac J Trop Biomed       Date:  2011-10

Review 5.  Choice of wound care in diabetic foot ulcer: A practical approach.

Authors:  Karakkattu Vijayan Kavitha; Shalbha Tiwari; Vedavati Bharat Purandare; Sudam Khedkar; Shilpa Sameer Bhosale; Ambika Gopalakrishnan Unnikrishnan
Journal:  World J Diabetes       Date:  2014-08-15

Review 6.  Diabetic Foot Infections: Update on Management.

Authors:  Maria Nikoloudi; Ioanna Eleftheriadou; Anastasios Tentolouris; Ourania A Kosta; Nikolaos Tentolouris
Journal:  Curr Infect Dis Rep       Date:  2018-08-01       Impact factor: 3.725

7.  Perioperative high inspired oxygen fraction therapy reduces surgical site infection with Pseudomonas aeruginosa in rats.

Authors:  Jeffrey S Kroin; Jinyuan Li; Josef W Goldufsky; Kajal H Gupta; Masoomeh Moghtaderi; Asokumar Buvanendran; Sasha H Shafikhani
Journal:  J Med Microbiol       Date:  2016-06-14       Impact factor: 2.472

8.  An Integrated HOCl-Producing E-Scaffold Is Active against Monomicrobial and Polymicrobial Biofilms.

Authors:  Laure Flurin; Yash S Raval; Abdelrhman Mohamed; Kerryl E Greenwood-Quaintance; Edison J Cano; Haluk Beyenal; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

9.  Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing.

Authors:  Josef Goldufsky; Stephen J Wood; Vijayakumar Jayaraman; Omar Majdobeh; Lin Chen; Shanshan Qin; Chunxiang Zhang; Luisa A DiPietro; Sasha H Shafikhani
Journal:  Wound Repair Regen       Date:  2015-07-27       Impact factor: 3.617

10.  Bacterial Silver Resistance Gained by Cooperative Interspecies Redox Behavior.

Authors:  Michael Muller
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.